IOL Chemicals and Pharmaceuticals Limited — Board Meeting, 10-08-2026: Outcome of Board Meeting
10-08-2026 | 02:18 pm
10-08-2026 | 02:18 pm
IOL Chemicals & Pharma's Board has approved the financial results for the quarter ended June 30, 2026. Consolidated Revenue from Operations soared to ₹756.26 Cr, with Net Profit reaching ₹64.40 Cr and EPS at ₹2.19.
No comments yet. Be the first to comment!
All announcements from IOL Chemicals and Pharmaceuticals Limited
